Dataset ID,Center name,Area of study,Assay,Method,Physical detection,Date Updated,Date Retrieved from Center,Cell,Small molecule ID,Description,Full assay name,Link to Source,Dataset ID
LDS-*,HMS LINCS,Binding assay,Binding assay,KINOMEScan,qPCR,,07/15/2011,,"LSM-1061, LSM-1209, LSM-1141, LSM-1159, LSM-6345, LSM-6303, LSM-6340, LSM-1028, LSM-5613, LSM-1055, LSM-1059, LSM-1060, LSM-1101, LSM-1065, LSM-1066, LSM-1067, LSM-1071, LSM-1092, LSM-1096, LSM-36386, LSM-1002, LSM-1018, LSM-1008, LSM-6015, LSM-1029, LSM-1046, LSM-1049, LSM-1050, LSM-1006, LSM-1009, LSM-1010, LSM-1012, LSM-1013, LSM-5394, LSM-1014, LSM-1027, LSM-5803, LSM-1079, LSM-6343, LSM-6344, LSM-1080, LSM-5970, LSM-1086, LSM-6296, LSM-6297, LSM-6298, LSM-6299, LSM-6300, LSM-1064, LSM-1104, LSM-6308, LSM-6306, LSM-6305, LSM-6304, LSM-1073, LSM-1230, LSM-1190, LSM-1106, LSM-1058, LSM-1051, LSM-1068, LSM-1001, LSM-6711, LSM-6712, LSM-1173, LSM-1047, LSM-1093, LSM-4255, LSM-1094, LSM-1224, LSM-1147, LSM-1035, LSM-5577, LSM-1025, LSM-1163, LSM-1210, LSM-1214, LSM-5982, LSM-5431, LSM-5245, LSM-1026, LSM-1085, LSM-5545, LSM-1070, LSM-1045, LSM-1043, LSM-1041, LSM-1003, LSM-1215, LSM-1120, LSM-5674, LSM-1024, LSM-1040, LSM-1129, LSM-1172, LSM-1105, LSM-1213, LSM-6709, LSM-36387, LSM-1184, LSM-1053, LSM-5749",,,http://lincs.hms.harvard.edu/kinomescan/,LDS-*
LDS-*,HMS LINCS,Binding assay,Binding assay,KiNativ,Mass spectrometry,,07/15/2011,"HeLa, PC-3 , Ramos (RA 1), MDA-MB-468, BCWM.1, NGP","LSM-1080, LSM-1106, LSM-1086, LSM-1008, LSM-1029, LSM-1046, LSM-1049, LSM-1050, LSM-1068, LSM-1079, LSM-1092, LSM-1070, LSM-5577, LSM-1093, LSM-1094, LSM-6299, LSM-1202, LSM-1201, LSM-6015, LSM-6708, LSM-6340, LSM-5803, LSM-1129, LSM-1189",,,http://lincs.hms.harvard.edu/kinativ/,LDS-*
LDS-1002,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-09-25,11/13/2015,"PC-9, NCI-H1648, NCI-H1648, IST-MEL1, IA-LM, COLO-800","LSM-1104, LSM-1041, LSM-1105, LSM-1103, LSM-1014, LSM-1021, LSM-1106, LSM-1102","Moerke 2 Color Apoptosis: IA-LM, IST-MEL1, NCI-H1648, PC-9 and SK-LMS-1 cells. Dose response of anti-mitotic compounds in human cancer cell lines at 24, 48, and 72 hours to determine their effects on apoptosis.  In this assay, the cell-permeable DNA dye Hoechst 33342 is used to stain the nuclei of all cells.  The fluorescent caspase 3 reporter NucView488 stains the nuclei of cells undergoing apoptosis (in which caspase 3 is active).",Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20001/,LDS-1002
LDS-1003,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-02-07,09/03/2015,"SK-LMS-1, NCI-H810, KYSE-180, KYSE-140, HUTU-80, BPH-1, 5637 (LCL-1702)","LSM-1104, LSM-1041, LSM-1105, LSM-1103, LSM-1014, LSM-1021, LSM-1106, LSM-1102","Moerke 3 Color Apoptosis: Dose response of anti-mitotic compounds in human cancer cell lines at 24 and 48 hours to determine their effects on apoptosis and cell death.  In this assay, the cell-permeable DNA dye Hoechst 33342 is used to stain the nuclei of all cells.  The fluorescent caspase 3 reporter NucView488 stains the nuclei of cells undergoing apoptosis (in which caspase 3 is active), and the cell-impermeable DNA dye TO-PRO3 stains only the nuclei of dead or dying cells in which membrane integrity is compromised.",Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20002/,LDS-1003
LDS-1004,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-02-07,09/03/2015,"WiDr, T24, SW620, SW527, SK-OV-3, PL4, PE/CA-PJ15, NCI-H2023, NCI-H1915, NCI-H1651, MT-3, MDA-MB-435S, LNZTA3WT4, KYSE-450, KYSE-150, KYSE-140, KMRC-20, JHH-6, Ishikawa (Heraklio) 02 ER-, Ishikawa, HLF, HEC-1, FU97, COLO-679, Calu-3, Calu-1, CAL-51, Ca9-22, Ca Ski, AGS, A375.S2, 647-V, 5637(LCL-1702)","LSM-1041, LSM-1066, LSM-1021, LSM-1062, LSM-1067, LSM-1065, LSM-1105, LSM-1102","Tang Mitosis/Apoptosis ver.II: Dose response of anti-mitotic compounds in human cancer cell lines at 24, 48 and 72 hours to determine effect on apoptosis, mitosis and cell death. 

In screening for small-molecule compounds that are effective at killing cancer cells, one-dimensional readout GI50, which is the EC50 value of growth inhibition, is usually used as the only criterion. A major problem with this one-readout approach is that other useful information is discarded, which could be critical for understanding the action of the compounds. In this screen, we use a single-cell-based imaging assay that can report multi-dimensional physiological responses in cells treated with small molecule kinase inhibitors. The data in this dataset are described in PMID: 23788527: Differential Determinants of Cancer Cell Insensitivity to Antimitotic Drugs Discriminated by a One-Step Cell Imaging Assay (J. Biomolecular Screening, 2013). The image analysis algorithm is available at https://github.com/xietiao/Tang_et_al_LINCS_cell_scoring.",Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20003/,LDS-1004
LDS-1005,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-02-07,09/03/2015,"SNB75, SK-MES, SK-LMS-1, SJCRH30, PC-9, NCI-H810, NCI-H1703, NCI-H1648, KYSE-180 KYSE-140, KATO III, IST-MEL1, IA-LM, HUTU-80, COLO-800, BPH-1, 5637(LCL-1702)","LSM-1104, LSM-1041, LSM-1105, LSM-1103, LSM-1014, LSM-1021, LSM-1106, LSM-1102","Tang Proliferation/Mitosis: Dose response of anti-mitotic compounds in human cancer cell lines at 24, 48 and 72 hours to determine effect on cell proliferation and mitosis.",Fluorescence imaging cell cycle state assay,http://lincs.hms.harvard.edu/db/datasets/20004/,LDS-1005
LDS-1106,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-05-02,09/03/2015,"ZR75B, LY2, HCC3153, HCC2185, 600MPE, T47DKBLUC, MX-1, MCF12A, 184A1, SUM52PE, SUM229PE, SUM225CWN, SUM185PE, SUM159PT, SUM149PT, SUM1315MO2, MCF10F, MCF10A, HCC1187, 184B5, ZR-75-1, UACC-893, UACC-812, T47D, MDA-MB-468, MDA-MB-453, MDA-MB-436, MDA-MB-361, MDA-MB-175-VII, MDA-MB-157, MDA-MB-134-VI, MB157, Hs578T, HCC70, HCC38, HCC202, HCC1954, HCC1937, HCC1806, HCC1569, HCC1428, HCC1419, HCC1395, HCC1143, CAMA-1, BT-549, BT-483, BT-474, BT-20, AU565, MDA-MB-231, SK-BR-3, MCF7","LSM-1013, LSM-1021, LSM-1023, LSM-1026, LSM-1035, LSM-1062, LSM-1097, LSM-1098, LSM-1102, LSM-1107, LSM-1108, LSM-5742, LSM-1143, LSM-1147, LSM-1173, LSM-1176, LSM-1190, LSM-1224, LSM-2309, LSM-1231, LSM-4258, LSM-5870, LSM-6359, LSM-4261, LSM-6281, LSM-4265, LSM-4266, LSM-4267, LSM-4268, LSM-2167, LSM-6360, LSM-4062, LSM-2078, LSM-6348, LSM-4272, LSM-5333, LSM-4276, LSM-4278, LSM-4279, LSM-5732, LSM-6350, LSM-4284, LSM-6263, LSM-2042, LSM-4287, LSM-6351, LSM-6352, LSM-4290, LSM-6361, LSM-6362, LSM-4295, LSM-5662, LSM-3524, LSM-3810, LSM-6302, LSM-3828, LSM-4298, LSM-6355, LSM-6356, LSM-6357, LSM-6363, LSM-6358",Metrics other than potency reveal systematic variation in responses to cancer drugs,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20020/,LDS-1106
LDS-1122,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-02-07,09/03/2015,"T47D, MCF10A, HCC1954, AU565","LSM-1098, LSM-6357, LSM-1173, LSM-1057, LSM-3810, LSM-4255",Breast cell line dose response to target inhibition measured by high throughput microscopy,Fluorescence imaging Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20136/,LDS-1122
LDS-1123,HMS LINCS,Binding assay,Binding assay,ELISA,Chemiluminescence,2015-09-23,11/13/2015,"184B5, AU565, BT-20, BT-474, BT-483, BT-549, CAMA-1, HCC1187, HCC1395, HCC1419, HCC1428, HCC1500, HCC1569, HCC1806, HCC1937, HCC1954, HCC202, HCC38, HCC70, Hs 578T, MCF 10A, MCF 10F, MCF12A, MCF7, MDA-MB-134-VI, MDA-MB-157, MDA-MB-175-VII, MDA-MB-231, MDA-MB-361, MDA-MB-415, MDA-MB-436, MDA-MB-453, MDA-MB-468, SK-BR-3, T47D, UACC-812, UACC-893, ZR-75-1, ZR-75-30",,Basal profile of receptor tyrosine kinase signaling network measured by ELISA,ELISA Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20137/,LDS-1123
LDS-1124,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-05-22,09/03/2015,"ZR-75-30, ZR-75-1, UACC-893, UACC-812, T47D, SK-BR-3, MDA-MB-453, MDA-MB-415, MDA-MB-361, MDA-MB-231, MDA-MB-175-VII, MDA-MB-157, MDA-MB-134-VI, MCF7, MCF12A, MCF 10F, MCF 10A, Hs 578T, HCC70, HCC38, HCC202, HCC1954, HCC1937, HCC1806, HCC1569, HCC1500, HCC1428, HCC1419, HCC1395, HCC1187, CAMA-1, BT-549, BT-483, BT-474, BT-20, AU565, 184B5",,Cell signaling response to growth factors measured by high throughput microscopy,Fluorescence imaging Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20138/,LDS-1124
LDS-1125,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2014-05-22,09/03/2015,"ZR-75-30, ZR-75-1, UACC-893, UACC-812, T47D, SK-BR-3, MDA-MB-453, MDA-MB-415, MDA-MB-361, MDA-MB-231, MDA-MB-175-VII, MDA-MB-157, MDA-MB-134-VI, MCF7, MCF12A, MCF 10F, MCF 10A, Hs 578T, HCC70, HCC38, HCC202, HCC1954, HCC1937, HCC1806, HCC1569, HCC1500, HCC1428, HCC1419, HCC1395, HCC1187, CAMA-1, BT-549, BT-483, BT-474, BT-20, AU565, 184B5",,Cell signaling response to cytokines measured by high throughput microscopy,Fluorescence imaging Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20139/,LDS-1125
LDS-1126,HMS LINCS,Binding assay,Binding assay,ELISA,Chemiluminescence,2015-09-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, AU565, BT-20, BT-474, BT-483, BT-549, CAMA-1, HCC1395, HCC1419, HCC1428, HCC1569, HCC1806, HCC1937, HCC1954, HCC202, HCC38, HCC70, Hs 578T, MDA-MB-134-VI, MDA-MB-157, MDA-MB-175-VII, MDA-MB-361, MDA-MB-415, MDA-MB-436, MDA-MB-453, MDA-MB-468, T47D, UACC-812, UACC-893, ZR-75-1, ZR-75-30, 184B5, HCC1187, HCC1500, MCF 10A, MCF 10F, MCF12A, BT-549, CAMA-1",,"To generate the growth factor “signaling profile” set, we exposed approximately 40 breast cancer cell lines individually to fifteen different growth factors (protein ligands) for 10, 30, or 90 min. We monitored the response by measuring the phosphorylation state of ERK1/2 and Akt using ELISA.",ELISA Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20140/,LDS-1126
LDS-1191,BroadT LINCS,Transcriptomics,L1000,L1000,Flow cytometry,,06/22/2015,"WSU-DLCL2,  Huh7, SNG-M, DV-90, NCI-H596, HT115, VCaP,  A549,  A-375, BT-20, MDST8, SW-948, SK-MEL-1, NCI-H716, HT-29, U-937, SW620, Hep G2, A673, HCT 116, SK-BR-3, MDA-MB-231, EFO-27, HCC-15, RMG-I, MCF7, THP-1, PC-3, NCI-H2073, TYK-nu, AGS, SH-SY5Y, Hs 578T, NCI-H1694, LoVo, COR-L23, NCI-H1836, NOMO-1, SK-LU-1",txt file,L1000 perturbational profiles,L1000 mRNA profiling assay,http://www.lincscloud.org/l1000/,LDS-1191
LDS-1194,BroadT LINCS,Transcriptomics,L1000,L1000,Flow cytometry,,05/30/2014,U-2 OS,txt file,L1000 perturbational profiles,L1000 mRNA profiling assay,http://www.lincscloud.org/l1000/,LDS-1194
LDS-1195,BroadT LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,,05/30/2014,U-2 OS,txt file,Fluorescence Imaging Multiplex Cytological Profiling Assay,Fluorescence imaging multiplex cytological profiling assay,http://www.lincscloud.org/imaging/,LDS-1195
LDS-1196,LINCS PCCSE,Proteomics,P100,P100,Mass spectrometry,,01/28/2016,"MCF7, PC-3, HL-60","LSM-2962, LSM-4062, LSM-2499, LSM-2167, LSM-5496, LSM-6504, LSM-6504, LSM-2405, LSM-2401, LSM-5044, LSM-5427, LSM-5886, LSM-5082, LSM-5427, LSM-2962, LSM-5082, LSM-2511",P100 Phosphosite Profiling Assay,P100 phosphoProtein_Metadata.txt quantification assay,https://panoramaweb.org/labkey/project/LINCS/LINCS_Phase_I/P100_Validation_Data/begin.view?,LDS-1196
LDS-1202,BroadT LINCS,Transcriptomics,L1000,L1000,Flow cytometry,,06/22/2015,"BT-20, LNCaP, SK-BR-3, MDA-MB-231, MCF7, Hs578T","LSM-1079, LSM-1064, LSM-1047, LSM-5068, LSM-1183, LSM-1057, LSM-1057, LSM-1079, LSM-1047, LSM-1064, LSM-1047, LSM-1183",,L1000 mRNA profiling assay,http://www.lincscloud.org/l1000/,LDS-1202
LDS-1203,BroadT LINCS,Transcriptomics,L1000,L1000,Flow cytometry,,09/03/2015,"BT-20, SK-BR-3, MDA-MB-231, MCF7, Hs578T","LSM-1054, LSM-1066, LSM-1006, LSM-6019, LSM-1032, LSM-1162, LSM-1040, LSM-5749, LSM-1062, LSM-1026, LSM-1096, LSM-1022, LSM-1044, LSM-1049, LSM-5067, LSM-1018, LSM-5245, LSM-1120, LSM-5982, LSM-1051, LSM-5394, LSM-1074, LSM-1093, LSM-1056, LSM-1053, LSM-1011, LSM-5970, LSM-5674, LSM-1177, LSM-1004, LSM-1011, LSM-1070, LSM-1166, LSM-1070, LSM-1003, LSM-1026, LSM-1026, LSM-1041, LSM-1035, LSM-1003, LSM-1035, LSM-1043, LSM-1180, LSM-1042, LSM-1079, LSM-1085, LSM-1043, LSM-1024, LSM-1020, LSM-1013, LSM-1024, LSM-1069, LSM-1064, LSM-1097, LSM-1134, LSM-1180, LSM-1024, LSM-1086, LSM-5613, LSM-1182, LSM-1081, LSM-1048, LSM-1094, LSM-1032, LSM-1026, LSM-1023, LSM-1072, LSM-1023, LSM-1060, LSM-1012, LSM-1118, LSM-1049, LSM-1058, LSM-1023, LSM-1074, LSM-1074, LSM-1139, LSM-1031, LSM-1098, LSM-1094, LSM-1096, LSM-1136, LSM-1047, LSM-1006, LSM-1024, LSM-1133, LSM-1045, LSM-1114, LSM-1097, LSM-1096, LSM-1054, LSM-1056, LSM-1065, LSM-1136, LSM-1169, LSM-1031, LSM-1068, LSM-1020, LSM-1009, LSM-1121, LSM-1183, LSM-1037, LSM-1161, LSM-5610, LSM-1041, LSM-1046, LSM-1013, LSM-1050, LSM-1157, LSM-1080, LSM-1055, LSM-1009, LSM-1101, LSM-1042, LSM-1012, LSM-1026, LSM-5610, LSM-1130, LSM-1152, LSM-1096, LSM-1131, LSM-1153, LSM-1010, LSM-1057, LSM-1130, LSM-1007, LSM-5006, LSM-1059, LSM-1005, LSM-1085, LSM-1057, LSM-1048, LSM-1161, LSM-1079, LSM-1002, LSM-1101, LSM-1081, LSM-1162, LSM-1085, LSM-1086, LSM-1068, LSM-1037, LSM-1127, LSM-1161, LSM-1005, LSM-1011, LSM-1047, LSM-1034, LSM-1061, LSM-1153, LSM-1069, LSM-1142, LSM-1028, LSM-1054, LSM-1182, LSM-1023, LSM-1040, LSM-1027, LSM-1063, LSM-1115, LSM-1061, LSM-1161, LSM-1099, LSM-1007, LSM-1120, LSM-1036, LSM-1073, LSM-1027, LSM-1098, LSM-1026, LSM-1051, LSM-1097, LSM-1028, LSM-1044, LSM-1023, LSM-1062, LSM-1053, LSM-1010, LSM-1033, LSM-1036, LSM-1166, LSM-1134, LSM-1064, LSM-1101, LSM-1033, LSM-1034, LSM-1177, LSM-1160, LSM-1178, LSM-1053, LSM-1067, LSM-1073, LSM-1049, LSM-1169, LSM-1080, LSM-1018, LSM-1048, LSM-5803, LSM-1067, LSM-1115, LSM-1045, LSM-1051, LSM-1056, LSM-1093, LSM-1065, LSM-1012, LSM-1022, LSM-1142, LSM-1114, LSM-1025, LSM-1069, LSM-1058, LSM-1046, LSM-1047, LSM-1098, LSM-1172, LSM-1031, LSM-1192, LSM-1067, LSM-1157, LSM-1060, LSM-1139, LSM-1010, LSM-1183, LSM-1055, LSM-1036, LSM-1172, LSM-1023, LSM-1059, LSM-1068, LSM-1059, LSM-1139, LSM-1098, LSM-1050, LSM-1170, LSM-1158, LSM-1127, LSM-1072, LSM-1032, LSM-1071, LSM-1121, LSM-1071, LSM-1192, LSM-1004, LSM-1063, LSM-1002, LSM-1151, LSM-1042, LSM-1099, LSM-1066, LSM-1011, LSM-1025",L1000 gene expression profiling assay - LJP,L1000 mRNA profiling assay,http://www.lincscloud.org/l1000/,LDS-1203
LDS-1206,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-07-01,09/03/2015,"MDA-MB-231, HME1","LSM-1047, LSM-1057, LSM-1064, LSM-1079, LSM-1101",Sensitivity measures of MDA-MB-231 and HME-1 cell lines to LINCS Pilot Phase TransCenter Project kinase inhibitors,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20215/,LDS-1206
LDS-1207,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-07-01,09/03/2015,"MDA-MB-231, HME1","LSM-1047, LSM-1057, LSM-1101, LSM-1079, LSM-1064",Metrics for growth responses of MDA-MB-231 and HME-1 cell lines to LINCS Pilot Phase TransCenter Project kinase inhibitors,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20216/,LDS-1207
LDS-1208,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-04-10,09/03/2015,"SKMEL28, K2, MZ7-mel, MMAC-SF, LOXIMVI, WM1552C, WM-115, RVH-421, COLO858, C32","LSM-1046, LSM-1049, LSM-1050, LSM-1056, LSM-1068",Viability and apoptosis in BRAF(V600E/D) melanoma cell lines monitored by imaging,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20217/,LDS-1208
LDS-1209,HMS LINCS,Proteomics,RPPA,Reverse Phase Protein Array,Fluorescence intensity,2015-08-25,09/03/2015,"SKMEL28, K2, MZ7-mel, MMAC-SF, LOXIMVI, WM1552C, WM-115, RVH-421, COLO858, C32","LSM-1046, LSM-1049, LSM-1050, LSM-1056, LSM-1068",Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by Reverse Phase Protein Arrays (RPPA),RPPA Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20218/,LDS-1209
LDS-1210,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-04-10,09/03/2015,"WM1552C, WM-115, LOXIMVI, COLO858","LSM-1068, LSM-36360",Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging,Fluorescence imaging Protein_Metadata.txt state assay,http://lincs.hms.harvard.edu/db/datasets/20219/,LDS-1210
LDS-1219,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-04-17,09/03/2015,"WM1552C, WM-115, SKMEL28, RVH-421, MZ7-mel, MMAC-SF, LOXIMVI, K2, COLO858, C32",,PLSR model loadings (pMEK and pERK included) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20229/,LDS-1219
LDS-1220,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-04-17,09/03/2015,"WM1552C, WM-115, SKMEL28, RVH-421, MZ7-mel, MMAC-SF, LOXIMVI, K2, COLO858, C32",,PLSR model loadings (pMEK and pERK excluded) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20230/,LDS-1220
LDS-1221,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-04-17,09/03/2015,"WM1552C, WM-115, SKMEL28, RVH-421, MZ7-mel, MMAC-SF, LOXIMVI, K2, COLO858 ,C32",,Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20231/,LDS-1221
LDS-1222,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-07-02,09/03/2015,"HeLa ICRP Bcl-XL-mCherry, HeLa ICRP Bcl-2-mCherry, HeLa ICRP FLIP-S-mCherry, HeLa ICRP FLIP-L-mCherry, HeLa ICRP",LSM-6281,Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20232/,LDS-1222
LDS-1223,HMS LINCS,Binding assay,Binding assay,Bead-based immunoassay,Fluorescence intensity,2015-08-27,09/03/2015,"N2586, RA2159","LSM-1048,LSM-1231,LSM-1139,LSM-1227,LSM-2309,LSM-1228,LSM-1126,LSM-1035,LSM-36360",Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors,Bead-based immunoassay for Protein_Metadata.txt state,http://lincs.hms.harvard.edu/db/datasets/20233/,LDS-1223
LDS-1224,HMS LINCS,Binding assay,Binding assay,Bead-based immunoassay,Fluorescence intensity,2015-07-15,09/03/2015,"N2586,RA2159","LSM-36360, LSM-6712, LSM-2309, LSM-1227",Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2),Bead-based immunoassay for Protein_Metadata.txt state,http://lincs.hms.harvard.edu/db/datasets/20234/,LDS-1224
LDS-1225,HMS LINCS,Binding assay,Binding assay,Bead-based immunoassay,Fluorescence intensity,2015-07-16,09/03/2015,"N2586, RA2159","LSM-36360, LSM-6712, LSM-2309, LSM-1227",Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2),Bead-based immunoassay for Protein_Metadata.txt state,http://lincs.hms.harvard.edu/db/datasets/20235/,LDS-1225
LDS-1226,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20237/,LDS-1226
LDS-1227,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20238/,LDS-1227
LDS-1228,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20239/,LDS-1228
LDS-1229,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20240/,LDS-1229
LDS-1230,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20241/,LDS-1230
LDS-1231,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20242/,LDS-1231
LDS-1232,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-08-25,09/03/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-5742, LSM-1035, LSM-1011, LSM-1004, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-1067, LSM-1041, LSM-1028, LSM-1132, LSM-4257, LSM-1122, LSM-1046, LSM-1191, LSM-1031, LSM-4256, LSM-1162, LSM-1045, LSM-1063, LSM-5577, LSM-6015, LSM-5431, LSM-5545, LSM-6299, LSM-1178, LSM-1148, LSM-1055, LSM-1120, LSM-1117, LSM-1025, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-1141, LSM-1020, LSM-1127, LSM-1069, LSM-1097, LSM-1158, LSM-1040, LSM-1047, LSM-1098, LSM-1108, LSM-1173, LSM-1134, LSM-1147, LSM-1128, LSM-1014, LSM-5982, LSM-5245, LSM-1023, LSM-36386, LSM-5674, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-1057, LSM-1018, LSM-1099, LSM-1152, LSM-1061, LSM-4255, LSM-1024, LSM-1071, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1116, LSM-1112, LSM-1072, LSM-1125, LSM-1073, LSM-1126, LSM-1049, LSM-5803, LSM-6019, LSM-1001, LSM-1139, LSM-1149, LSM-1032, LSM-1056, LSM-1052, LSM-1008, LSM-1119, LSM-1142, LSM-1172, LSM-1079, LSM-1080, LSM-1021, LSM-1143, LSM-1111, LSM-1068, LSM-1064, LSM-5970, LSM-1086, LSM-1150, LSM-1109, LSM-1053",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 7: Mean cell count and growth rate across all replicates.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20243/,LDS-1232
LDS-1233,BroadT LINCS,Transcriptomics,L1000,L1000,Flow cytometry,,07/17/2015,"A-375, A549, BT-20, HA1E, HCC515, Hep G2, HME1, Hs 578T, HT-29, LNCaP, MCF10A, MCF7, MDA-MB-231, PC-3, SK-BR-3","LSM-1200, LSM-1207, LSM-6333, LSM-6332, LSM-1175, LSM-1045, LSM-1204, LSM-1180, LSM-1133, LSM-5463, LSM-1035, LSM-1011, LSM-1002, LSM-1003, LSM-1118, LSM-6320, LSM-1034, LSM-1054, LSM-1225, LSM-1004, LSM-1155, LSM-1050, LSM-36357, LSM-5218, LSM-1140, LSM-1159, LSM-1059, LSM-1006, LSM-1007, LSM-1165, LSM-6308, LSM-42751, LSM-1067, LSM-5351, LSM-1041, LSM-1041, LSM-4571, LSM-1164, LSM-1028, LSM-1132, LSM-1144, LSM-1137, LSM-1190, LSM-1178, LSM-6305, LSM-1148, LSM-1189, LSM-1055, LSM-4256, LSM-6264, LSM-1195, LSM-1120, LSM-1186, LSM-5006, LSM-1058, LSM-1610, LSM-1025, LSM-1202, LSM-1187, LSM-1181, LSM-1010, LSM-1009, LSM-1027, LSM-6321, LSM-6342, LSM-1141, LSM-1203, LSM-6303, LSM-1223, LSM-6329, LSM-1020, LSM-6708, LSM-5855, LSM-6306, LSM-1170, LSM-1127, LSM-4811, LSM-1069, LSM-5661, LSM-1097, LSM-4258, LSM-6271, LSM-1158, LSM-1040, LSM-1110, LSM-42745, LSM-6341, LSM-1182, LSM-1047, LSM-4257, LSM-1098, LSM-1373, LSM-1173, LSM-1062, LSM-1134, LSM-1147, LSM-1222, LSM-1030, LSM-1012, LSM-1013, LSM-1128, LSM-42747, LSM-42749, LSM-6328, LSM-1173, LSM-1029, LSM-1014, LSM-6345, LSM-6344, LSM-5982, LSM-5245, LSM-6015, LSM-6343, LSM-1022, LSM-6334, LSM-6335, LSM-1129, LSM-1205, LSM-1023, LSM-6317, LSM-1206, LSM-6339, LSM-6336, LSM-1157, LSM-36386, LSM-1209, LSM-5674, LSM-6318, LSM-1092, LSM-1188, LSM-1031, LSM-1033, LSM-1043, LSM-1065, LSM-1044, LSM-1081, LSM-1198, LSM-1201, LSM-1154, LSM-1196, LSM-1197, LSM-1194, LSM-1074, LSM-1156, LSM-1193, LSM-1051, LSM-1115, LSM-1183, LSM-1135, LSM-36359, LSM-1130, LSM-6323, LSM-6330, LSM-1124, LSM-2481, LSM-1153, LSM-1057, LSM-1066, LSM-5344, LSM-1042, LSM-1018, LSM-1099, LSM-1152, LSM-1070, LSM-2191, LSM-1061, LSM-1122, LSM-42748, LSM-4255, LSM-1184, LSM-6710, LSM-1208, LSM-1024, LSM-1145, LSM-1145, LSM-36398, LSM-1063, LSM-1179, LSM-6340, LSM-1071, LSM-1114, LSM-1101, LSM-1026, LSM-1048, LSM-1160, LSM-1166, LSM-4254, LSM-1116, LSM-1112, LSM-1072, LSM-6331, LSM-1125, LSM-6304, LSM-1073, LSM-1126, LSM-1191, LSM-1049, LSM-1151, LSM-6322, LSM-1163, LSM-5803, LSM-5394, LSM-6019, LSM-1037, LSM-6437, LSM-1226, LSM-2557, LSM-6283, LSM-6324, LSM-1113, LSM-1001, LSM-4947, LSM-1139, LSM-1149, LSM-1174, LSM-1032, LSM-1032, LSM-1168, LSM-1161, LSM-1036, LSM-1121, LSM-42746, LSM-1056, LSM-1171, LSM-6307, LSM-1123, LSM-1052, LSM-1052, LSM-1008, LSM-1119, LSM-1192, LSM-1176, LSM-1167, LSM-1060, LSM-4259, LSM-1142, LSM-1172, LSM-1131, LSM-1005, LSM-1079, LSM-1080, LSM-1021, LSM-1136, LSM-1143, LSM-5578, LSM-1111, LSM-1224, LSM-6325, LSM-6338, LSM-6337, LSM-1199, LSM-36358, LSM-1146, LSM-1068, LSM-3828, LSM-3828, LSM-1169, LSM-5431, LSM-6685, LSM-1064, LSM-5970, LSM-5545, LSM-1085, LSM-5749, LSM-1086, LSM-6297, LSM-1093, LSM-1094, LSM-5577, LSM-6299, LSM-1177, LSM-1150, LSM-1109, LSM-1096, LSM-1053, LSM-5601, LSM-1146",L1000 Connectivity Map perturbational profiles from Broad Institute LINCS Center for Transcriptomics (NIH U54HL127366),L1000 mRNA profiling assay,http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70138,LDS-1233
LDS-1234,LINCS PCCSE,Proteomics,P100,P100,Mass spectrometry,,01/28/2016,"MCF7, PC-3 ,A549","LSM-1063, LSM-1103, LSM-1108, LSM-2557, LSM-2597, LSM-3524, LSM-3828, LSM-4571, LSM-4811, LSM-4886, LSM-4923, LSM-4942, LSM-5123, LSM-5351, LSM-5855, LSM-6328, LSM-6330, LSM-6332, LSM-6334, LSM-6335, LSM-6338, LSM-19036, LSM-36361, LSM-36362, LSM-36363, LSM-36364, LSM-36365, LSM-36366, LSM-36368, LSM-36369, LSM-36370, LSM-42750",P100 Epigenetics compounds,P100 phosphoProtein_Metadata.txt quantification assay,https://panoramaweb.org/labkey/project/LINCS/P100/begin.view?,LDS-1234
LDS-1235,LINCS PCCSE,Proteomics/Epigenomics,GCP,GCP,Mass spectrometry,,01/08/2016,"MCF7, A-375, PC-3, A549","LSM-1063, LSM-1103, LSM-1108, LSM-2557, LSM-2597, LSM-3524, LSM-3828, LSM-4571, LSM-4811, LSM-4886, LSM-4923, LSM-4942, LSM-5123, LSM-5351, LSM-5855, LSM-6328, LSM-6330, LSM-6332, LSM-6334, LSM-6335, LSM-6338, LSM-19036, LSM-36361, LSM-36362, LSM-36363, LSM-36364, LSM-36365, LSM-36366, LSM-36368, LSM-36369, LSM-36370, LSM-42750",,Global chromatin epigenetic profiling assay,https://panoramaweb.org/labkey/project/LINCS/GCP/begin.view?,LDS-1235
LDS-1236,LINCS PCCSE,Proteomics/Epigenomics,GCP,GCP,Mass spectrometry,,01/08/2016,,"LSM-1074, LSM-1103, LSM-1139, LSM-1141, LSM-1145, LSM-1181, LSM-1217, LSM-1471, LSM-2135, LSM-2787, LSM-3557, LSM-3828, LSM-4192, LSM-4521, LSM-5512, LSM-6264, LSM-6348, LSM-36361, LSM-36971, LSM-37157, LSM-42752, LSM-42753, LSM-42754, LSM-42755, LSM-42756, LSM-42757, LSM-42758, LSM-42759, LSM-42760, LSM-42761, LSM-42773",,Global chromatin epigenetic profiling assay,https://panoramaweb.org/labkey/project/LINCS/GCP/begin.view?,LDS-1236
LDS-1237,DToxS,Transcriptomics,RNA-Seq,RNA-Seq,DNA sequencing,,06/30/2015,"PromoCell cardiomyocytes  Line A, PromoCell cardiomyocytes  Line  B, PromoCell cardiomyocytes  Line D","LSM-6555, LSM-3365, LSM-2850, LSM-1176, LSM-36378, LSM-2843, LSM-1008, LSM-5258, LSM-5038, LSM-1023, LSM-2160, LSM-5933, LSM-1297, LSM-3493",,,https://martip03.u.hpc.mssm.edu/data.php,LDS-1237
LDS-1238,NeuroLINCS,Transcriptomics,RNA-Seq,RNA-Seq,DNA sequencing,,06/30/2015,iPSC,,,RNA-seq gene expression profiling assay,http://www.neurolincs.org/data,LDS-1238
LDS-1239,DToxS,Transcriptomics,RNA-Seq,RNA-Seq,DNA sequencing,,08/20/2015,"PromoCell cardiomyocytes  Line A, PromoCell cardiomyocytes  Line  B, PromoCell cardiomyocytes  Line D,  PromoCell cardiomyocytes  Line E","LSM-6555, LSM-2850, LSM-3365, LSM-1176, LSM-24954, LSM-1008, LSM-5258, LSM-5038, LSM-2280, LSM-1023, LSM-1097, LSM-5725, LSM-1020, LSM-5470, LSM-5690, LSM-1227, LSM-1190, LSM-1199, LSM-1051, LSM-1114, LSM-1139, LSM-5742, LSM-3493, LSM-5933, LSM-1297",The overall goal is to develop robust cellular signatures for drug-induced toxicity and toxicity mitigation. These signatures will be established by exposing cells to drugs and drug combinations in culture followed by RNA sequencing.,,https://martip03.u.hpc.mssm.edu/data.php,LDS-1239
LDS-1240,MEP LINCS,Imaging,MEMA ,MEMA ,Fluorescence intensity,,03/06/2016,PC3,,MEP-LINCs PC3 SS2,MEMA cell growth assay,https://www.synapse.org/#!Synapse:syn4719716,LDS-1240
LDS-1242,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-11-25,09/15/2015,COLO858,LSM-1068,,Fluorescence imaging cell cycle state assay,http://lincs.hms.harvard.edu/db/datasets/20236/,LDS-1242
LDS-1249,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-16,11/13/2015,"BT-20, MCF10A, MCF7, MDA-MB-231, Hs 578T, SK-BR-3","LSM-1045, LSM-1067",High-content imaging of six breast cancer cell lines treated with a library of small molecule kinase inhibitors.,Fluorescence imaging cell viability assay,http://lincs.hms.harvard.edu/db/datasets/20244/,LDS-1249
LDS-1250,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20124/,LDS-1250
LDS-1251,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20247/,LDS-1251
LDS-1252,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20247/,LDS-1252
LDS-1253,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20248/,LDS-1253
LDS-1254,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20249/,LDS-1254
LDS-1255,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20250/,LDS-1255
LDS-1256,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2015-12-23,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001, LSM-1004, LSM-1006, LSM-1007, LSM-1008, LSM-1009, LSM-1010, LSM-1011, LSM-1014, LSM-5982, LSM-5245, LSM-6015, LSM-1018, LSM-5674, LSM-1020, LSM-1021, LSM-1023, LSM-1024, LSM-1025, LSM-1026, LSM-1027, LSM-1028, LSM-1031, LSM-1032, LSM-1035, LSM-5431, LSM-1040, LSM-1041, LSM-1045, LSM-1046, LSM-1047, LSM-1048, LSM-1049, LSM-1051, LSM-1052, LSM-1053, LSM-1055, LSM-1056, LSM-1057, LSM-1059, LSM-1061, LSM-1063, LSM-1064, LSM-1067, LSM-1068, LSM-1069, LSM-1071, LSM-1072, LSM-1073, LSM-5803, LSM-6019, LSM-1079, LSM-1080, LSM-5545, LSM-5970, LSM-1086, LSM-5577, LSM-6299, LSM-1097, LSM-1098, LSM-1099, LSM-36386, LSM-1101, LSM-1108, LSM-1109, LSM-1111, LSM-1112, LSM-1115, LSM-1116, LSM-1117, LSM-1119, LSM-1120, LSM-1122, LSM-1125, LSM-1126, LSM-1127, LSM-1128, LSM-1132, LSM-1134, LSM-1135, LSM-1139, LSM-1141, LSM-1142, LSM-1143, LSM-1147, LSM-1148, LSM-1149, LSM-1150, LSM-1152, LSM-1158, LSM-1159, LSM-1160, LSM-1162, LSM-1165, LSM-1172, LSM-1173, LSM-1178, LSM-1181, LSM-1183, LSM-1191, LSM-4255, LSM-4256, LSM-4257, LSM-2481, LSM-6548, LSM-668",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20251/,LDS-1256
LDS-1257,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2016-01-07,11/13/2015,"MCF7, SK-BR-3, MDA-MB-231, BT-20, Hs578T, MCF10A","LSM-1001,LSM-1004,LSM-1006,LSM-1007,LSM-1008,LSM-1009,LSM-1010,LSM-1011,LSM-1014,LSM-5982,LSM-5245,LSM-6015,LSM-1018,LSM-5674,LSM-1020,LSM-1021,LSM-1023,LSM-1024,LSM-1025,LSM-1026,LSM-1027,LSM-1028,LSM-1031,LSM-1032,LSM-1035,LSM-5431,LSM-1040,LSM-1041,LSM-1045,LSM-1046,LSM-1047,LSM-1048,LSM-1049,LSM-1051,LSM-1052,LSM-1053,LSM-1055,LSM-1056,LSM-1057,LSM-1059,LSM-1061,LSM-1063,LSM-1064,LSM-1067,LSM-1068,LSM-1069,LSM-1071,LSM-1072,LSM-1073,LSM-5803,LSM-6019,LSM-1079,LSM-1080,LSM-5545,LSM-5970,LSM-1086,LSM-5577,LSM-6299,LSM-1097,LSM-1098,LSM-1099,LSM-36386,LSM-1101,LSM-1108,LSM-1109,LSM-1111,LSM-1112,LSM-1115,LSM-1116,LSM-1117,LSM-1119,LSM-1120,LSM-1122,LSM-1125,LSM-1126,LSM-1127,LSM-1128,LSM-1132,LSM-1134,LSM-1135,LSM-1139,LSM-1141,LSM-1142,LSM-1143,LSM-1147,LSM-1148,LSM-1149,LSM-1150,LSM-1152,LSM-1158,LSM-1159,LSM-1160,LSM-1162,LSM-1165,LSM-1172,LSM-1173,LSM-1178,LSM-1181,LSM-1183,LSM-1191,LSM-4255,LSM-4256,LSM-4257,LSM-2481,LSM-6548,LSM-6685",LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose response metrics.,Fluorescence imaging apoptosis assay,http://lincs.hms.harvard.edu/db/datasets/20252/,LDS-1257
LDS-1261,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2016-02-04,11/13/2015,"MCF7, MCF10A, MDA-MB-231, BT-20, SK-BR-3","LSM-1147, LSM-1071, LSM-1099, LSM-1049, LSM-1024, LSM-1097, LSM-1135, LSM-1051",Breast Cancer Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values.,Fluorescence imaging cell viability assay,http://lincs.hms.harvard.edu/db/datasets/20256/,LDS-1261
LDS-1262,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2016-02-04,11/13/2015,"Hs 578T, MCF7, MCF10A, MDA-MB-231, BT-20, SK-BR-3","LSM-1147, LSM-1099, LSM-1049, LSM-1024, LSM-1071, LSM-1097, LSM-1051, LSM-1135",Breast Cancer Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates.,Fluorescence imaging cell viability assay,http://lincs.hms.harvard.edu/db/datasets/20257/,LDS-1262
LDS-1263,HMS LINCS,Imaging,Viability,Fluorescence imaging,Fluorescence intensity,2016-02-04,11/13/2015,"MCF7,MCF10A,MDA-MB-231,BT-20,SK-BR-3","LSM-1024, LSM-1049, LSM-1071, LSM-1099, LSM-1147, LSM-1051, LSM-1097, LSM-1135",Breast Cancer Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 3 of 3: Calculated dose response metrics.,Fluorescence imaging cell viability assay,http://lincs.hms.harvard.edu/db/datasets/20258/,LDS-1263
LDS-1264,LINCS PCCSE,Proteomics,P100,P100,Mass spectrometry,,11/13/2015,MFC7,"LSM-1011,LSM-1028,LSM-1056,LSM-1068,LSM-1071,LSM-1101,LSM-1099,LSM-1114,LSM-1142,LSM-1163,LSM-1186,LSM-1227,LSM-3828,LSM-4255,LSM-4256,LSM-5975,LSM-6267,LSM-6306,LSM-36361,LSM-42769,LSM-5313,LSM-3347,LSM-42762,LSM-42763,LSM-42764,LSM-42765,LSM-42766,LSM-42767,LSM-42768,LSM-6187,LSM-3514",,,https://panoramaweb.org/labkey/project/LINCS/P100/begin.view?,LDS-1264
LDS-1265,LINCS PCCSE,Proteomics,GCP,GCP,Mass spectrometry,,01/08/2016,"MCF7, A-375","LSM-1011, LSM-1028, LSM-1056, LSM-1068, LSM-1071, LSM-1101, LSM-1099, LSM-1103, LSM-1114, LSM-1142, LSM-1163, LSM-1186, LSM-1227, LSM-3828, LSM-4255, LSM-4256, LSM-5975, LSM-6267, LSM-6306, LSM-36361, LSM-42769, LSM-5313, LSM-3347, LSM-42762, LSM-42763, LSM-42764, LSM-42765, LSM-42766, LSM-42767, LSM-42768, LSM-6187, LSM-3514",,,https://panoramaweb.org/labkey/project/LINCS/GCP/begin.view?,LDS-1265
LDS-1266,DToxS,Proteomics,Mass spectrometry,MS/MS,Mass spectrometry,,01/04/2016,PromoCell cardiomyocytes Line D,"LSM-1139, LSM-1097, LSM-1098, LSM-1099, LSM-1114, LSM-1190, LSM-1199, LSM-1226, LSM-5742, LSM-5438, LSM-1176, LSM-1227",,MS protein state assay,https://martip03.u.hpc.mssm.edu/index.php?login=1,LDS-1266